Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Nimodipine adverse reaction |
Causative agent (attribute) |
True |
Nimodipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to nimodipine |
Causative agent (attribute) |
False |
Nimodipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
nimodipine 200 microgrammes/mL, fiole de 50 mL pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nimodipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely nimodipine 30 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nimodipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely nimodipine 30 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nimodipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing nimodipine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nimodipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to nimodipine |
Causative agent (attribute) |
True |
Nimodipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nimodipine 30 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nimodipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nimodipine 30 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Nimodipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nimodipine 30 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nimodipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nimodipine 30 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Nimodipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nimodipine 30 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Nimodipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nimodipine 30 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Nimodipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nimodipine 10 milligram/50 milliliter conventional release solution for infusion vial |
Has basis of strength substance (attribute) |
False |
Nimodipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nimodipine 10 milligram/50 milliliter conventional release solution for infusion vial |
Has precise active ingredient |
False |
Nimodipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing nimodipine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nimodipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nimodipine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nimodipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only nimodipine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nimodipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nimodipine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nimodipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nimodipine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nimodipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nimodipine 200 microgram/1 milliliter conventional release solution for infusion (clinical drug) |
Has precise active ingredient |
True |
Nimodipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nimodipine 200 microgram/1 milliliter conventional release solution for infusion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Nimodipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nimodipine 200 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Nimodipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nimodipine 200 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Nimodipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nimodipine 200 microgram/mL solution for infusion and/or injection |
Has precise active ingredient |
True |
Nimodipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nimodipine 200 microgram/mL solution for infusion and/or injection |
Has basis of strength substance (attribute) |
True |
Nimodipine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |